Characterization of the B Cell Receptor Repertoire in the Intestinal Mucosa and of Tumor-Infiltrating Lymphocytes in Colorectal Adenoma and Carcinoma.
Zhang, W
Feng, Q
Wang, C
Zeng, X
Du, Y
Lin, L
Wu, J
Fu, L
Yang, K
Xu, X
Xu, H
Zhao, Y
Li, X
Schoenauer, UH
Stadlmayr, A
Saksena, NK
Tilg, H
Datz, C
Liu, X
- Publisher:
- The American Association of Immunologists
- Publication Type:
- Journal Article
- Citation:
- J Immunol, 2017, 198, (9), pp. 3719-3728
- Issue Date:
- 2017-05-01
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
Characterization_of_the_B_Cell_Receptor_Repertoire_in_t.pdf | Published version | 2.53 MB | Adobe PDF |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Zhang, W | |
dc.contributor.author | Feng, Q | |
dc.contributor.author | Wang, C | |
dc.contributor.author | Zeng, X | |
dc.contributor.author | Du, Y | |
dc.contributor.author | Lin, L | |
dc.contributor.author | Wu, J | |
dc.contributor.author | Fu, L | |
dc.contributor.author | Yang, K | |
dc.contributor.author | Xu, X | |
dc.contributor.author |
Xu, H https://orcid.org/0000-0003-1129-5337 |
|
dc.contributor.author | Zhao, Y | |
dc.contributor.author | Li, X | |
dc.contributor.author | Schoenauer, UH | |
dc.contributor.author | Stadlmayr, A | |
dc.contributor.author | Saksena, NK | |
dc.contributor.author | Tilg, H | |
dc.contributor.author | Datz, C | |
dc.contributor.author | Liu, X | |
dc.date.accessioned | 2024-03-12T04:02:41Z | |
dc.date.available | 2017-02-23 | |
dc.date.available | 2024-03-12T04:02:41Z | |
dc.date.issued | 2017-05-01 | |
dc.identifier.citation | J Immunol, 2017, 198, (9), pp. 3719-3728 | |
dc.identifier.issn | 0022-1767 | |
dc.identifier.issn | 1550-6606 | |
dc.identifier.uri | http://hdl.handle.net/10453/176553 | |
dc.description.abstract | The B cells inhabited in mucosa play a vital role in mediating homeostasis with autoantigens and external Ags. Tumor-infiltrating lymphocytes are potential prognostic markers and therapeutic agents for cancer. However, the spatial heterogeneity of the B cell repertoire in intestinal mucosa and the tumor-infiltrating lymphocytes in colorectal cancer (CRC) remain poorly understood. In this study, we developed an unbiased method to amplify the IgH repertoire, as well as a bioinformatic pipeline to process these high-throughput sequencing data. With biopsies from seven intestinal mucosal segments, we uncovered their strong spatial homogeneity among the large intestine, where the clone overlap rate was up to 62.21%. The heterogeneity between terminal ileum and large intestine was also observed, including discrepant isotype distribution and low clone overlap rate. With tumor and adjacent normal mucosal tissues from CRC and colorectal advanced adenoma (AD) patients, we observed a similar IgH profile between tumor and adjacent normal mucosal tissues in AD, as well as a slight difference in CRC. Interestingly, we found distinct repertoire properties in the CRC tumor from AD and normal mucosa. Finally, we identified 1445 public clones for the normal mucosa, and 22 public clones for the CRC tumor with characteristic features. These data may be of potential use in clinical prognosis, diagnosis, and treatment of CRC. | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.publisher | The American Association of Immunologists | |
dc.relation.ispartof | J Immunol | |
dc.relation.isbasedon | 10.4049/jimmunol.1602039 | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | 1107 Immunology | |
dc.subject.classification | Immunology | |
dc.subject.classification | 3101 Biochemistry and cell biology | |
dc.subject.classification | 3204 Immunology | |
dc.subject.mesh | Adenoma | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Aged, 80 and over | |
dc.subject.mesh | B-Lymphocytes | |
dc.subject.mesh | Biopsy | |
dc.subject.mesh | Cell Line, Tumor | |
dc.subject.mesh | Colonic Neoplasms | |
dc.subject.mesh | Colorectal Neoplasms | |
dc.subject.mesh | Computational Biology | |
dc.subject.mesh | Genetic Variation | |
dc.subject.mesh | High-Throughput Nucleotide Sequencing | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Immunoglobulin Heavy Chains | |
dc.subject.mesh | Intestinal Mucosa | |
dc.subject.mesh | Lymphocytes, Tumor-Infiltrating | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Neoplasm Staging | |
dc.subject.mesh | Receptors, Antigen, B-Cell | |
dc.subject.mesh | Intestinal Mucosa | |
dc.subject.mesh | B-Lymphocytes | |
dc.subject.mesh | Lymphocytes, Tumor-Infiltrating | |
dc.subject.mesh | Cell Line, Tumor | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Adenoma | |
dc.subject.mesh | Colorectal Neoplasms | |
dc.subject.mesh | Colonic Neoplasms | |
dc.subject.mesh | Receptors, Antigen, B-Cell | |
dc.subject.mesh | Biopsy | |
dc.subject.mesh | Neoplasm Staging | |
dc.subject.mesh | Computational Biology | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Aged, 80 and over | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Immunoglobulin Heavy Chains | |
dc.subject.mesh | Genetic Variation | |
dc.subject.mesh | High-Throughput Nucleotide Sequencing | |
dc.subject.mesh | Adenoma | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Aged, 80 and over | |
dc.subject.mesh | B-Lymphocytes | |
dc.subject.mesh | Biopsy | |
dc.subject.mesh | Cell Line, Tumor | |
dc.subject.mesh | Colonic Neoplasms | |
dc.subject.mesh | Colorectal Neoplasms | |
dc.subject.mesh | Computational Biology | |
dc.subject.mesh | Genetic Variation | |
dc.subject.mesh | High-Throughput Nucleotide Sequencing | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Immunoglobulin Heavy Chains | |
dc.subject.mesh | Intestinal Mucosa | |
dc.subject.mesh | Lymphocytes, Tumor-Infiltrating | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Neoplasm Staging | |
dc.subject.mesh | Receptors, Antigen, B-Cell | |
dc.title | Characterization of the B Cell Receptor Repertoire in the Intestinal Mucosa and of Tumor-Infiltrating Lymphocytes in Colorectal Adenoma and Carcinoma. | |
dc.type | Journal Article | |
utslib.citation.volume | 198 | |
utslib.location.activity | United States | |
utslib.for | 1107 Immunology | |
pubs.organisational-group | University of Technology Sydney | |
pubs.organisational-group | University of Technology Sydney/Faculty of Engineering and Information Technology | |
pubs.organisational-group | University of Technology Sydney/Faculty of Engineering and Information Technology/School of Computer Science | |
utslib.copyright.status | closed_access | * |
dc.date.updated | 2024-03-12T04:02:39Z | |
pubs.issue | 9 | |
pubs.publication-status | Published | |
pubs.volume | 198 | |
utslib.citation.issue | 9 |
Abstract:
The B cells inhabited in mucosa play a vital role in mediating homeostasis with autoantigens and external Ags. Tumor-infiltrating lymphocytes are potential prognostic markers and therapeutic agents for cancer. However, the spatial heterogeneity of the B cell repertoire in intestinal mucosa and the tumor-infiltrating lymphocytes in colorectal cancer (CRC) remain poorly understood. In this study, we developed an unbiased method to amplify the IgH repertoire, as well as a bioinformatic pipeline to process these high-throughput sequencing data. With biopsies from seven intestinal mucosal segments, we uncovered their strong spatial homogeneity among the large intestine, where the clone overlap rate was up to 62.21%. The heterogeneity between terminal ileum and large intestine was also observed, including discrepant isotype distribution and low clone overlap rate. With tumor and adjacent normal mucosal tissues from CRC and colorectal advanced adenoma (AD) patients, we observed a similar IgH profile between tumor and adjacent normal mucosal tissues in AD, as well as a slight difference in CRC. Interestingly, we found distinct repertoire properties in the CRC tumor from AD and normal mucosa. Finally, we identified 1445 public clones for the normal mucosa, and 22 public clones for the CRC tumor with characteristic features. These data may be of potential use in clinical prognosis, diagnosis, and treatment of CRC.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph